Correlation Between Vivos Therapeutics and Boston Scientific

Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and Boston Scientific at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and Boston Scientific into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vivos Therapeutics and Boston Scientific Corp, you can compare the effects of market volatilities on Vivos Therapeutics and Boston Scientific and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of Boston Scientific. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and Boston Scientific.

Diversification Opportunities for Vivos Therapeutics and Boston Scientific

0.48

Correlation Coefficient

Vivos Therapeutics  Boston Scientific

Very weak diversification

The 3 months correlation between Vivos and Boston is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and Boston Scientific Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Boston Scientific Corp and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with Boston Scientific. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Boston Scientific Corp has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and Boston Scientific go up and down completely randomly.

Pair Corralation between Vivos Therapeutics and Boston Scientific

Given the investment horizon of 90 days Vivos Therapeutics is expected to under-perform the Boston Scientific. In addition to that, Vivos Therapeutics is 5.06 times more volatile than Boston Scientific Corp. It trades about -0.09 of its total potential returns per unit of risk. Boston Scientific Corp is currently generating about -0.07 per unit of volatility. If you would invest  10,383  in Boston Scientific Corp on July 5, 2025 and sell it today you would lose (572.50) from holding Boston Scientific Corp or give up 5.51% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Vivos Therapeutics  vs.  Boston Scientific Corp

Vivos Therapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days Vivos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in November 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Boston Scientific Corp

Risk-Adjusted Performance

Weakest

Over the last 90 days Boston Scientific Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Boston Scientific is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Vivos Therapeutics and Boston Scientific

The main advantage of trading using opposite Vivos Therapeutics and Boston Scientific positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, Boston Scientific can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boston Scientific will offset losses from the drop in Boston Scientific's long position.

The idea behind Vivos Therapeutics and Boston Scientific Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.